Search Results - Nandeuil, M-A

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients

    A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients by Singh, D, Leaker, B, Boyce, M, Nandeuil, M.A, Collarini, S, Mariotti, F, Santoro, D, Barnes, P.J

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers

    Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy voluntee... by Mariotti, Fabrizia, Govoni, Mirco, Lucci, Germano, Santoro, Debora, Nandeuil, Marie Anna

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT)

    Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT) by Beeh, Kai M, Emirova, Aida, Prunier, Hélène, Santoro, Debora, Nandeuil, Marie Anna

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    D37 COPD: DEVELOPMENTAL THERAPEUTICS: Safety, Tolerability And Pharmacokinetic Profile Of Chf6001, A Novel Selective Inhaled Pde4 Inhibitor, In Healthy Volunteers

    D37 COPD: DEVELOPMENTAL THERAPEUTICS: Safety, Tolerability And Pharmacokinetic Profile Of Chf6001, A Novel Selective Inhaled Pde4 Inhibitor, In Healthy Volunteers by Nandeuil, M-A, Mariotti, F, Lucci, G, Santoro, D, Poli, G, Acerbi, D

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    C31 INFLAMMATORY MEDIATORS AND MECHANISMS IN ASTHMA: The Effect Of The Inhaled Pde4 Inhibitor Chf6001 On Allergen-Induced Inflammation In Asthmatic Subjects

    C31 INFLAMMATORY MEDIATORS AND MECHANISMS IN ASTHMA: The Effect Of The Inhaled Pde4 Inhibitor Chf6001 On Allergen-Induced Inflammation In Asthmatic Subjects by Singh, D, Leaker, B R, Boyce, M, Nandeuil, M A, Collarini, S, Mariotti, F, Santoro, D, Barnes, P J

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: